Clinical Trials Browser

Phase 2 × Bile Duct Neoplasms × Trifluridine × Clear all

NCT04072445 2023-08-09

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

Phase 2 Completed

28 enrolled 20 charts

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms